Buy Retatrutide 40mg Peptide Pen UK | GLP-1 Research Peptide
Buy Retatrutide 40mg Peptide Pen UK | GLP-1 Research Peptide
Buy Retatrutide 40mg Peptide Pen UK | GLP-1 Research Peptide
Buy Retatrutide 40mg Peptide Pen UK | GLP-1 Research Peptide — Retatrutide 40mg peptide pen supplied for laboratory research purposes. This convenient pen-format delivery system contains Retatrutide, a synthetic triple agonist peptide targeting the GLP-1, GIP, and glucagon receptors, manufactured to ≥99% purity and HPLC-verified for use in scientific research. Dispatched from the UK with a Certificate of Analysis available upon request.
For in-vitro and laboratory research use only. Not for human or animal consumption, personal use, or self-administration.
Kit Contents
- 1 × Retatrutide 40mg peptide pen (pre-filled, ready for research use)
- Pen format for precise volume delivery in laboratory settings
Retatrutide 40mg Peptide Pen Research Information
Retatrutide (LY3437943) is an investigational peptide developed by Eli Lilly and Company. As a GLP-1 research peptide and triple incretin receptor agonist, it simultaneously targets GLP-1, GIP, and glucagon receptors, making it a key research tool in metabolic biology. The TRIUMPH-1 Phase 3 trial topline results (May 2026) reported a mean body weight reduction of 28.3% at 80 weeks, with 45.3% of participants achieving ≥30% weight reduction at the highest dose. The 40mg pen format provides a higher-dose research option for studies requiring larger quantities.
Areas of Scientific Interest
- Triple incretin receptor agonism (GLP-1, GIP, glucagon)
- Metabolic rate and energy expenditure research
- Adipose tissue biology and lipid metabolism
- Insulin sensitivity and glucose homeostasis models
- Comparative agonist pharmacology across incretin receptor subtypes
- Body weight regulation and energy balance research
- Higher-dose metabolic research protocols
Product Specifications
- Product: Retatrutide 40mg Peptide Pen
- Quantity: 40mg
- Format: Pre-filled peptide pen
- Purity: ≥99%
- Verification: HPLC-tested, Certificate of Analysis available
- Intended use: Research purposes only
- Storage: Store at 2–8°C (refrigerated), away from light
- Dispatched from the UK
Research Applications
The Retatrutide 40mg Peptide Pen is of significant interest to researchers requiring higher-dose GLP-1 triple agonist protocols. The pen format enables precise, consistent volume delivery in laboratory settings. It is also available as a Retatrutide 20mg vial for lower-dose research protocols. All applications are strictly for qualified laboratory research use.
Storage & Handling
Store the Retatrutide 40mg Peptide Pen at 2–8°C (refrigerated), protected from light. Do not freeze the pen format. Handle under sterile laboratory conditions. For research use only.
Frequently Asked Questions
What is the Retatrutide 40mg Peptide Pen?
The Retatrutide 40mg Peptide Pen is a pre-filled pen-format GLP-1 triple agonist research peptide supplied strictly for in-vitro and laboratory research purposes.
Is the Retatrutide 40mg Peptide Pen available in the UK?
Yes. The Retatrutide 40mg Peptide Pen GLP-1 research peptide is dispatched from the UK with a Certificate of Analysis available upon request.
What purity is the Retatrutide 40mg Peptide Pen?
All Retatrutide 40mg Peptide Pen units are manufactured to ≥99% purity and independently HPLC-verified.
Can I buy the Retatrutide 40mg Peptide Pen in the UK for research?
The Retatrutide 40mg Peptide Pen is available for qualified laboratory research applications. It is not intended for human or animal use.
For research use only. Not for human consumption, therapeutic use, or veterinary use.
Also available as a Retatrutide 20mg vial and Retatrutide Peptide Pen. Related research peptides: MOTS-C 10mg, NAD+ 500mg. View our full research peptide range.